Loading...
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
APGE
APGE News & Events
-
Add to Watchlist
Trade APGE
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
APGE News
Apogee Therapeutics (APGE) Options Volume Surges 46.6% Today
6 days ago
NASDAQ.COM
Stocks to Consider Buying in 2026: Insights from Our Roundtable Experts, Including DoorDash and LVMH
Jan 16 2026
Barron's
Apogee Therapeutics CMO Sells $1.46 Million in Shares
Jan 11 2026
NASDAQ.COM
Apogee Therapeutics CMO Sells $1.46 Million in Shares Following Options Exercise
Jan 11 2026
Fool
Apogee Therapeutics CMO Sells 10,900 Shares for $817,500
Jan 08 2026
Fool
APGE Options Offer 9.33% Yield Boost on $75 Put Contract
Jan 07 2026
NASDAQ.COM
Apogee Therapeutics Reports 60% FeNO Reduction in Phase 1b Trial of APG777 for Asthma
Jan 06 2026
Benzinga
Apogee Therapeutics Reports Positive Phase 1b Data for Zumilokibart in Asthma, Plans Phase 3 Trial in 2026
Jan 06 2026
NASDAQ.COM
Show More News
APGE Events
01/23 12:10
Apogee Therapeutics Shares Down 13.0% to $69.44
Apogee Therapeutics is down -13.0%, or -$10.42 to $69.44.
Show More Events
APGE Monitor News
No relevant news for Apogee Therapeutics Inc.
Jan 23 2026
APGE Earnings Analysis
No Data
People Also Watch